Antibiotic misuse: A global crisis with a unique Indian twist
In a world where antibiotic resistance is an ever-looming threat, a recent study published in The Lancet Public Health has shed light on a critical issue: the misuse of powerful antibiotics, particularly in India. This study, a comprehensive analysis of antibiotic use across 186 countries, reveals a double-edged challenge—overuse in some regions and underuse in others, with India presenting a unique case study.
The Global Antibiotic Landscape
The World Health Organization (WHO) has categorized antibiotics into three groups: 'access,' 'watch,' and 'reserve.' Each category serves a specific purpose, with 'access' antibiotics being the first line of defense for common infections, 'watch' antibiotics reserved for specific, harder-to-treat infections, and 'reserve' antibiotics, the last resort for multidrug-resistant infections.
The study estimates that globally, around 43 billion antibiotic treatment days were needed in 2019, highlighting a delicate balance between ensuring access to these life-saving drugs and preventing their overuse, which fuels antimicrobial resistance.
India's Antibiotic Paradox
India's antibiotic use, as revealed by the study, presents a paradox. While the country legitimately requires more 'watch' antibiotics due to its higher burden of infectious diseases and antimicrobial resistance, the study suggests that these powerful antibiotics are being overused. Simultaneously, 'reserve' antibiotics, meant for last-resort situations, are underutilized.
The numbers are telling: India's antibiotic consumption stands at 18.3 defined daily doses (DID) per 1,000 people per day, with only 27% of this coming from the 'access' category, against an estimated requirement of 52.3%. This indicates a potential overreliance on 'watch' antibiotics and an underutilization of 'access' antibiotics, which are generally safer and less likely to drive resistance.
Implications and Way Forward
The implications of this misuse are far-reaching. Overuse of 'watch' antibiotics can lead to increased resistance, rendering these drugs ineffective when they are truly needed. Underuse of 'reserve' antibiotics, on the other hand, can leave patients with drug-resistant infections without the necessary treatment, potentially leading to severe health complications or even death.
Prof. Ramanan Laxminarayan, a study author and founder of One Health Trust, emphasizes the need for strategies that ensure populations have access to the right antibiotics at the right time while curbing unnecessary use. This delicate balance is crucial to combat the global threat of antimicrobial resistance.
A Call for Action
The study's findings serve as a wake-up call, not just for India but for the global community. With more than three-fourths of countries using more antibiotics than necessary, and almost every country overusing the most critical antibiotics, the time for action is now. As Prof. Laxminarayan suggests, improving antibiotic use requires a multifaceted approach, combining better access, appropriate prescribing practices, and a heightened awareness of the risks associated with antibiotic misuse.
In conclusion, the battle against antimicrobial resistance is a global one, and India's unique challenges offer valuable insights. By learning from these insights and implementing effective strategies, we can hope to preserve the efficacy of antibiotics, ensuring they remain a reliable tool in our healthcare arsenal for generations to come.
